Your browser does not support JavaScript!
首頁
劉崇喜教授

 

JournalPatenBook

 

劉崇喜教授      
辦公室:U715    
分   機:2715    

學歷:

高雄醫學院,藥學研究所博士班,博士 民國82年6月畢
現職:
大仁科技大學 藥學系 教授,95年7月~迄今 

經歷:
  1. 大仁科技大學 藥學暨健康學院 院長,97年8月~99年7月。
  2. 大仁技術學院中草藥科技研究中心 主任,91年8月~98年7月。
  3. 大仁技術學院 藥學系 系主任,89年2月~91年7月。
  4. 大仁藥專 藥學系 副教授82年7月-95年6月
  5. 大仁藥專 藥學系 講師81年7月~82年6月

Email:

專長:

  1. 中藥炮製學,中藥炮製是根據中醫藥理論,依照辨證施治用藥的需要和藥物自身性質,以及調劑、製劑的不同要求,所採取的一項製藥技術。它為專門研究中藥炮製理論、工藝、規格標準、歷史沿習及其發展方向的學科。
  2. 方劑學,方劑學是在中醫理論指導下研究藥物在臨床治療之技術的科學。本科目講述方劑之方名、組成、使用方法、功用、主治、方解、藥理作用、臨床應用、加減方、辨別方劑等。
 

 

 Journal Papers

  1. Y.C. Chen, C.C. Liaw, Y.B Cheng, Y.C. Lin, C.H. Chen, Y.T. Huang, S.S. Liou, S.Y. Chen, C.T.Chein, G.C.Lee, Y.C, Shen*. Anti-Liver Fibrotic Lignans from the Fruits of Schisandra Arisanensis and S.sphenanthera. Bioorganic & Medicinal Chemistry Letters.2013;23:880-885. (SCI)
  2. T.F. Tzeng, H.J. Lu, S.S. Liou, C.J. Chang, I.M. Liu. Cassia tora (Leguminosae) seed extract alleviates high-fat diet-induced nonalcoholic fatty liver.Food Chemistry Toxicol. 2013;51:194-201. (SCI)
  3. T.F. Tzeng, H.J. Lu, S.S. Liou, C.J. Chang, I.M. Liu. Reduction of lipid accumulation in white adipose tissues by Cassia tora(Leguminosae) seed extract is associated with AMPK activation. Food Chemistry. 2013;136(2):1086-1094. (SCI)
  4. W.C. Chen, S.S Liou, T.F. Tzeng, S.L Lee, I.M. Liu*. Wound repair and anti-inflammatory potential  of Lonicera japonica inf excision wound-induced rats.BMC Complementary and Alternative Medicine. 2012;12(1):226.(SCI)
  5. T.F. Tzeng, H.J. Lu, C.J. Chang, S.S Liou, I.M. Liu. Emodin protects against high-fat diet-induced obesity via regulation of AMP-activated protein kinase pathways in white adipose tissue. Planta Med. 2012;78(10):943-950. (SCI)
  6. C.J. Chang ,T.F. Tzeng, S.S Liou, Y.S. Chang, I.M. Liu. Absence of Genotoxic and Mutagenic Effects of Zingiber zerumbet(L.)Smith (Zingiberaceae) Extract. Evid Based Complement and Alternativet Medicine.2012; doi:10.1155/2012/406296. (SCI)
  7. T.F. Tzeng, H.J. Lu, S.S Liou, C.J. Chang, I.M. Liu. Emodin, a naturally occurring anthraquinone derivative, ameliorates dyslipidemia by activating AMP-activated protein kinase in high-fat-diet-fed  rats. Evid Based Complement and Alternativet Medicine.2012; doi:10.1155/2012/781812. (SCI)
  8. C.J. Chang ,T.F. Tzeng, S.S Liou, Y.S. Chang and I.M. Liu. Acute and 28-day subchronic oral toxicity of an ethanol extract of Zingiber zerumbet (L.) Smith in rodents. Evid Based Complement and Alternativet Medicine.2012; doi:10.1155/2012/608284. (SCI)
  9. C.J. Chang ,T.F. Tzeng, S.S Liou, Y.S. Chang and I.M. Liu. Myricetin increases Hepatic Peroxisome  Proliferator-Activated Receptor α Protein Expression and Decreases Plasma Lipids and Adiposity inf Rats. Evid Based Complement and Alternativet Medicine.2012; doi:10.1155/2012/787152. (SCI)
  10. T.F. Tzeng, H.J. Lu, S.S Liou, C.J. Chang, I.M. Liu. Vinegar-Baked Radix Bupleuri Regulates Lipid Disorders Via a Pathway Dependent on Peroxisome-Porliferator-Activated Receptor-α in High-Fat-Diet-induced Obese Rats. Evid Based Complement and Alternativet Medicine.2012; doi:10.1155/2012/827278. (SCI)
  11. I.M. Liu, T.F. Tzeng, S.S. Liou and C.J. Chang. Beneficial effect of Traditional Chinese medicinal Formula Danggui-Shaoyao-San on advanced glycation End-Product-Mediated renal injury in streptozotocin-diabetic rats. Evid Based Complement and Alternativet Medicine.2012; doi:10.1155/2012/140103. (SCI)
  12. C.J. Chang, T.F. Tzeng, S.S Liou, Y.S. Chang**, I.M.Liu*. Regulation of lipid disorders by ethanol extracts from Zingiber zerumbet in high-fat diet-induced rats. Food Chemistry.2012;132:460-467.
  13. I.M. Liu*, T.F.Tzeng, S.S. Liou, C.J. Chang. Regulation of obesity and lipid disorders by extracts from Angelica acutiloba root in high-fat diet-induced obese rats. Phytotherapy Research. 2012;26(2):223-230. (SCI)
  14. C.J. Chang, T.F. Tzeng, S.S. Liou, Y.S Chang, I.M. Liu. Kaempferol regulates the lipid-profile in high-fat diet-fed rats through an increase in hepatic PPARα levels. Planta Med. 2011 ;77(17): 1876-1882. (SCI)
  15. Y.B. Cheng, Y.C. Lin, A.T. Khalil, S.S Liou, G.C. Lee, Y.H. Kuo and Y.C. Shine*. Seven New Lignan Esters from Kadsura philippinensis. Helvetica Chimica Acta.2011;94(1):148-158. (SCI)
  16. I.M. Liu, T.F. Tzeng, S.S. Liou and C.J. Chang. Angelica Acutiloba Root Alleviates Advanced Glycation End-Product-Mediated Renal lnjury in Streptozotocin-Diabetic Rats. Journal of Food Science.2011;76(7)H165-174. (SCI)
  17. T.F. Tzeng, S.S. Liou and I.M.Liu. Myricetin Ameliorates Defective Post-Receptor Insulin Signaling  via b-Endorphin Signaling in the Skeletal Muscles of Fructose-Fed Rats. Evid Based Complement and Alternativet Medicine.2011;doi:10.1093/ecam/neq017. (SCI)
  18. M.C Lai. I.M. Liu, S.S.Liou and Y.S. Chang. Mesaconitine plays the major role in the antinociceptive and anti-inflammatory activities of radix Aconiti Carmichaeli (Chuan Wu). Journal of Food and Drug Analysis.2011;19(4):362-368. (SCI)
  19. H.C. Huang,Y.C. Lin,A.E. Fazary, I.W. Lo, C.C. Liaw, Y.Z. Huang, S.S. Liou,Y.C.Shen*. New and bioactive lignans from the fruits of Schisandra sphenanthera. Food Chemistry.2011;128:348-357. (SCI)
  20. I.M .Liu, T.F. Tzeng, S.S. Liou. A Chinese Herbal Decoction, Dang Gui Bu Xue Tang, Prepared from Radix Astragali and Radix Angelicae sinensis, Ameliorates Insulin Resistance Induced by A High-Fructose Diet in Rats. Evidence-based complementary alternative medicine . 2011;doi:10.1093/ecam/enq004. (SCI)
  21. I.M. Liu*, T.F. Tzeng, S.S. Liou,C.J. Chang. Angelica acutiloba Root Attenuates insulin Resistance  induced by High-Fructose Diet in Rats. Phytother Research.2011;doi:10.1002/ptr.3403. 2011;25(9):1283-1293. (SCI)
  22. C.C. Liu , A.E-R. MH, C.C. Liaw , Y.B. Cheng , C.K. Chen , C.T. Chien , Y.H. Kuo , S.S. Liou , Y.C. Shen .Arisanschinins A-E, Lignans from Schisandra arisanensis hay. Planta Med.2010;76(14): 1605-1610. (SCI)
  23. I.M. Liu*, T.F. Tzeng, S.S. Liou. Abelmoschus moschatus (Malvaceae), an aromatic plant, suitable for medical or food uses to improve insulin sensitivity. Phytother Research.2010;24(2):233-239. (NSC 94-2320-B-127-005) (SCI)
  24. Y.B.Cheng, M.T. Chang, Y.W. Lo, C.J. Ho, Y.C. Kuo, C.T.Chien, S.Y. Chen, S.S. Liou, Y.H. Kuo, Y.C. Shen*. Oxygenated Lignans from the Fruits of Schisandra arisanensis. Journal of natural products.2009;72(9):1663-1668. (SCI)
  25. I.M. Liu*, T.F. Tzeng, S.S. Liou, C.J. Chang.The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription. Journal of ethnopharmacology .2009;124(2):211-218. (SCI)
  26. Y.C. Shen*, Y.C. Lin, Y.B. Cheng, M.Y. Chiang, S.S. Liou, A.T. Khalil. Dibenzocyclooctadiene lignans from Kadsura philippinensis. Phytochemistry.2009;70(1):114-120. (SCI)
  27. Y.C. Shen*, Y.C. Lin, C.J. Chang, T.W. Lan, S.S. Liou, C.T. Chien, C.C. Liaw and A.T. Khalil. New Oxygenated Lignans from Kadsura philippinensis. Helvetica Chimica Acta,2008;91(3):483- 494. (SCI)
  28. I.M. Liu, W.J. Yu, S.S. Liou, T.F. Tzeng, I.H. Tsai and A.J.Cheng*. Role of Alcohol in the induction of Hepatic injury by Chronic Consumption of Medicated Wine. Journal of Food and Drug Analysis.2007;15(4):466-471. (SCI)
 

 TOP

 

Patent

  1. 劉崇喜;劉怡旻;陳威丞,『牛樟芝圓粒結構』,大陸實用新型專利,已核准證書字號:2628188,2012.6.28~2022.06.27。
  2. 劉崇喜;劉怡旻;李瑞瑜,『從山藥塊根外皮萃取抗氧化物質之製備方法』,中華民國發明專利,已核准證書字號:I379687,2012.12.21 ~ 2029.9.8。
  3. 劉崇喜;劉怡旻;陳威丞,『封閉式牛樟芝物流管控裝置』,中華民國新型專利,已核准證書字號:M443892,2012.12.21~2022.6.25。
  4. 劉崇喜;劉怡旻;黃郁婷,『抑制腫瘤的藥用真菌藥錠結構』,大陸實用新型專利,已核准證書字號:2544155,2011.12.9~2021.12.8。
  5. 劉崇喜;劉怡旻;陳威丞,『具有光照單元的牛樟芝培養箱』,大陸實用新型專利,已核准證書字號:2449463,2012.3.1~2022.2.31。
  6. 劉崇喜;劉怡旻;陳威丞,『牛樟芝物流管控裝置』,大陸實用新型專利,已核准證書字號:2448387,2012.1.20~2022.1.19。
  7. 劉崇喜;劉怡旻;陳威丞,『具有光照單元的牛樟芝培養箱』,中華民國新型專利,已核准證書字號:M433086,2012.7.11~2022.2.22。
  8. 劉崇喜;劉怡旻;陳威丞,『牛樟芝培養箱』,大陸實用新型專利,已核准證書字號:2239177,2011.9.29~2021.9.28。
  9. 劉崇喜;劉怡旻;陳威丞,『牛樟芝物流管控裝置』,中華民國新型專利,已核准證書字號:M429146,2012.5.11~2022.1.12。
  10. 劉怡旻;劉崇喜;張家茹,『薄荷抗氧化物質之恆溫萃取法』,中華民國發明專利,已核准證書字號:I361097,2012.4.1~2029.8.30。
  11. 劉崇喜;劉怡旻;黃郁婷,『具抑制腫瘤之藥用真菌藥錠結構』,中華民國新型專利,已核准證書字號:M425668,2012.4.1~2021.11.28。
  12. 劉崇喜;劉怡旻;陳威丞,『牛樟芝培養箱』,中華民國新型專利,已核准證書字號:M421698,2012.2.1~2021.9.22。
  13. 王伯綸;劉崇喜,劉怡旻;張家茹,『微膠囊』,大陸實用新型專利,已核准證書字號:1925283,2011.1.26~2021.1.25。
  14. 劉崇喜;劉怡旻;黃郁婷;張家茹,『四物滴丸』,中華民國新型專利,已核准證書字號:M408367,2011.8.1~2021.1.24。
  15. 劉崇喜;劉怡旻;黃郁婷;張家茹,『四物滴丸』,大陸實用新型專利,已核准證書字號:2300506,2011.7.15~2021.7.14。
  16. 王伯綸;劉崇喜,劉怡旻;張家茹,『當歸微膠囊』,中華民國新型專利,已核准證書字號:M404712,2011.6.1~2020.12.16。
  17. 劉崇喜;劉怡旻,『中藥當歸之定量定溫及定時炮製法』,中華民國發明專利,已核准證書字號:I339123,2011.3.21~2027.9.6。
  18. 劉崇喜;劉怡旻;張家茹;唐偉智,『一種預防或治療貧血之中草藥 複方萃取物.其製備方法及其醫藥組合物』,美國發明專利,已核准證書字號:US8,420,136 B2。
 

 TOP

Book

  1. 劉崇喜,『方劑學』,泓京出版社,2010.1
 

 TOP

 

 

瀏覽數  
將此文章推薦給親友
請輸入此驗證碼
Voice Play
更換驗證碼